Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Harvard Bioscience (HBIO) Asset Utilization Ratio (2016 - 2025)

Harvard Bioscience (HBIO) has disclosed Asset Utilization Ratio for 15 consecutive years, with 1.11 as the latest value for Q3 2025.

  • On a quarterly basis, Asset Utilization Ratio rose 47.12% to 1.11 in Q3 2025 year-over-year; TTM through Sep 2025 was 1.11, a 47.12% increase, with the full-year FY2024 number at 0.71, down 10.19% from a year prior.
  • Asset Utilization Ratio was 1.11 for Q3 2025 at Harvard Bioscience, roughly flat from 1.11 in the prior quarter.
  • In the past five years, Asset Utilization Ratio ranged from a high of 1.11 in Q2 2025 to a low of 0.68 in Q1 2021.
  • A 5-year average of 0.81 and a median of 0.78 in 2022 define the central range for Asset Utilization Ratio.
  • Peak YoY movement for Asset Utilization Ratio: decreased 9.89% in 2024, then soared 47.12% in 2025.
  • Harvard Bioscience's Asset Utilization Ratio stood at 0.75 in 2021, then grew by 3.09% to 0.78 in 2022, then increased by 4.5% to 0.81 in 2023, then fell by 9.89% to 0.73 in 2024, then surged by 51.41% to 1.11 in 2025.
  • Per Business Quant, the three most recent readings for HBIO's Asset Utilization Ratio are 1.11 (Q3 2025), 1.11 (Q2 2025), and 0.89 (Q1 2025).